The present invention relates to 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives having pharmacological activity
to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy and/or prophylaxis of a cognitive disorder.
本发明涉及具有药理活性的1-[1-(苯甲酰基)-
吡咯烷-2-羰基]-
吡咯烷-2-羧腈衍
生物的制备过程,包括它们的制药组合物以及它们在治疗和/或预防认知障碍方面的用途。